Aviva currently offers antibodies to more than 7,000 different protein targets due to their high throughput antibody production releases more than 200 new antibodies every month. Aviva's focus is antibodies to key targets in areas of transcription, epigenetics and cell signaling. Aviva places their emphasis on family-oriented antibody production has yielded antibodies to most members of key protein families such as Transcription Factors, Transcription Regulators, RNA Binding Proteins, Ion Channels, and Cell Membrane target proteins.
cancer related antibodies, transcription factor antibodies, ELISA Kits, fluorescence, immunohistochemistry, immunoprecipitation